The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.
Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
Date:
More like thisRelated
Oil Prices Creep Up as Investors Weigh Cease-Fire Extension
Oil prices stablized as investors scrambled to make sense...
Hoarding Is Driving Energy Prices Higher Everywhere
As wealthy nations scramble to secure stocks of oil,...
4 Takeaways From ‘Lorne,’ the Movie About Lorne Michaels and ‘S.N.L.’
The documentary offers a rare behind-the-scenes look at a...